Stem Cell-Based Therapy for Ischemic Heart Disease
Despite great advances in therapy over the past decades, ischemic heart disease (IHD) remains the leading cause of death worldwide because the decrease in mortality after acute myocardial infarction (AMI) leads to a longer life span in patients with chronic postinfarct heart failure (HF). There are...
Main Authors: | Lien-Cheng Hsiao M.D., Carolyn Carr D.Phil., Kuan-Cheng Chang, Shinn-Zong Lin, Kieran Clarke |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-04-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X655109 |
Similar Items
-
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease
by: Kai Zhu, et al.
Published: (2016-01-01) -
Stem Cell Therapy for Ischemic Heart Disease: Beginning or End of the Road?
by: Christof Stamm DR, et al.
Published: (2006-01-01) -
The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease
by: Chuanbin Liu, et al.
Published: (2021-04-01) -
The Role of Endothelial Progenitor Cells in Ischemic Cerebral and Heart Diseases
by: Dah-Ching Ding, et al.
Published: (2007-03-01) -
Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
by: Satsuki Yamada, et al.
Published: (2020-01-01)